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Background: Violacein is a purple pigment from Chromobacterium violaceum that possesses diverse biological and
pharmacological properties. Among these, pro-oxidant and antioxidant activities have been suggested. However,
the cytotoxic mechanisms induced by violacein are poorly understood and the improvement in knowledge regarding
these cell death mechanisms will be useful to develop new therapeutic approaches. Considering this, in our work, we
investigated the pro-oxidant effects of violacein in non-tumor (CHO-K1 and MRC-5) and tumor (HeLa) cell lines,
searching for a better understanding of reactive oxygen species (ROS) production and cell death induction.
Results: Cytotoxicity induced by violacein was observed in the three cell lines; however, MRC-5 and HeLa cells were
shown to be more sensitive to violacein treatment. Although punctual alterations in the antioxidant apparatus and
increase in oxidative stress biomarkers was observed in some violacein concentrations, no association was found
between increased oxidative stress and induction of cell death. However, the increase of mitochondrial membrane
potential was observed.
Conclusions: In fact, the increase of mitochondrial membrane potential in MRC-5 and HeLa cells suggests that
mitochondrial membrane hyperpolarization might be the main cause of cell death triggered by violacein.
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Violacein is a purple pigment produced by Chromobacter-
ium violaceum, a betaproteobacteria commonly found in
tropical and sub-tropical regions. This pigment has
attracted interest owing to its several biological and
pharmacological activities, including antibiotic [1–3], anti-
tumoral [4–6], antileishmanial [7], antiviral [8, 9], antipro-
tozoal and antiparasitary [10–12], immunomodulatory,
analgesic and antipyretic [13], anti-diarrheal and ulcer-
protective effects [14].
The antioxidant activity of violacein has been studied
in distinct models, as a scavenger of nitrogen reactive
species, 2,2-diphenyl-1-picrylhydrazyl (DPPH) radicals* Correspondence: lfagnez@ufrnet.br
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tion [15]. Despite this in vitro antioxidant potential, ROS
production mediated by violacein, followed by activation
of caspase-3, release of cytochrome c, calcium release to
the cytosol and apoptotic cell death, were reported in
colon cancer Caco-2 cells [16]. Moreover, the cytotox-
icity toward EAT cells mediated by ROS production and
the decrease in intracellular GSH levels were observed
after treatment with violacein [5].
Concerning these two contrasting effects (antioxidant
and pro-oxidant) and the limited number of cell lines
evaluated to date, the present study was carried out to
investigate the pro-oxidant effects of violacein in non-
tumor and tumor cell lines, aiming to perform a com-
parative analysis of the cellular responses and a better
understanding of the mechanisms involved with cellle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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Results
Violacein induced loss of cell viability and cell death by
necrosis or apoptosis
Thecell viability data obtained using the Trypan blue dye
exclusion method showed that, after incubation with
violacein for 24 h, MRC-5 and HeLa cells exhibited
nearly 60 % of cell viability when exposed to 6 μM viola-
cein. However, a weaker cytotoxicity was observed in
CHO-K1 cells (Fig. 1a). As shown in Fig. 1b, exposure to
3 μM violacein for 48 h caused an approximately 50 %
decrease in cell viability in all of the cell lines tested,
with MRC-5 and HeLa cells being more sensitive to the
treatment.
Annexin V is a recombinant phosphatidylserine-binding
protein that specifically interacts with phosphatidylserine
residues and can be used for the detection of apoptosis.
Cells treated with violacein were stained with Annexin-V
and PI for necrosis detection [17, 18]. In all of the concen-
trations tested, violacein could induce necrosis in CHO-
K1 cells due to the significant increase (p < 0.001) in
AnnexinV−/PI+ and AnnexinV+/PI+ cells (Fig. 2a). Al-
though AnnexinV+/PI+ is characteristic of both late apop-
totic or early necrotic cells, the low percentage of
AnnexinV+/PI− labeling, which is characteristic of early
apoptotic cells, might be an indication that cells present-
ing double staining (AnnexinV+/PI+) are undergoing ne-
crosis. For MRC-5 cells, labeling features of both necrotic
and apoptotic cells were observed with all of the concen-
trations tested (Fig. 2b). However, the percentage of nec-
rotic cells was significant with 6 μM violacein, suggesting
that necrosis might be the predominant cell death mech-
anism. By contrast, the results obtained with HeLa cells
showed that most of the cells displayed markers of early
and late apoptosis when exposed to violacein (Fig. 2c). AsFig. 1 Effects of violacein on the cell viability of CHO-K1, MRC-5 and HeLa
exposure to 0.75–6 μM violacein for 24 (a) and (b) 48 h. The viability of unobserved in the Trypan blue dye exclusion assays (Fig. 1)
and in the flow cytometric analysis, the decrease in cell
viability was not continuously observed, as higher concen-
trations were tested. However, there were differences be-
tween given concentrations. Fig. 2a-c also shows the dot
plots of Annevin V/FITC against PI (panels at right).
Effects on the antioxidant apparatus
As demonstrated in Fig.3a, in CHO-K1 cells, violacein at
1.5-6 μM led to an increase in SOD activity. Regarding
to MRC-5 cells, a significant increase in SOD levels was
observed specifically in cells exposed to violacein at
3 μM, but a decreased SOD activity was observed when
cells were submitted to 6 μM. In fact, the decrease was
observed either for HeLa cells submitted to violacein at
6 μM and one possible explanation for this decrease
might be violacein cytotoxicity at this concentration.
Considering the catalase assays, not even the highest
concentration tested caused significant changes in en-
zymatic activity in CHO-K1 and HeLa cells. In contrast,
in MRC-5 cells, violacein at 1.5 μM lead to the inhib-
ition of catalase activity, but it is not clear why this oc-
curs (Fig. 3b). A significant decrease in GSH levels was
observed in HeLa cells exposed to violacein at 0.75, 1.5
and 6 μM (Fig. 3c).
Oxidative stress biomarker detection
A significant increase in the protein carbonyl levels was
observed exclusively in CHO-K1 cells exposed to 1.5–
3 μM violacein (Fig. 4a). Regarding to lipid peroxidation
markers, increased lipid hydroperoxide levels were ob-
served in MRC-5 cells exposed to 3 μM violacein (Fig.4b).
In contrast, violacein was not able to increase the levels of
8-isoprostanes in any concentration tested (Fig. 4c). Inter-
estingly, a decrease in 8-oxoguanine (8-oxoG, a DNA oxi-
dized lesion) levels was observed in CHO-K1, MRC-5 and
Hella cells exposed to 1.5-6 μM violacein (Fig. 4d).cells, as determined by the Trypan blue dye exclusion method after
treated cells was expressed as 100 %
Fig. 2 Cells death induced by violacein determined by flow cytometry. The percentage of CHO-K1 (a), MRC-5 (b) and HeLa cells (c) exposed to
0.75–6 μM violacein presenting externalization of phosphatidylserine in the outer layer are shown. The Annexin V+/P− cells plus Annexin V+/PI+
cells were detected as apoptotic cells. Annexin V−/PI+ cells were labeled as necrotic cells. All of the results are expressed as the means ± SD of
three independent experiments (*p < 0.05 CHO-K1 vs. MRC-5 and HeLa cells; **p < 0.001 treated vs. control; ***p < 0.001 AnnexinV−/PI+ versus
AnnexinV−/PI− cells exposed to 6 μM violacein)
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Considering that RH123 uptake is proportional to the
mitochondrial transmembrane potential, the results
shows that violacein leads to the increase of the mito-
chondrial membrane potential (Fig. 5) in MRC-5 and
HeLa cells at all of the concentrations tested. By con-
trast, in CHO-K1 cells, no significant changes in the
membrane potential were detected. These data suggest
that the cytotoxicity induced by violacein may be due tomitochondrial damage that leads to membrane hyperpo-
larization, triggering cell death. However, the cytotoxicity
of violacein in CHO-K1 cells may be related to a viola-
cein cell-type specific mechanisms, other than the induc-
tion of mitochondrial membrane hyperpolarization.
Discussion
In general, the cytotoxicity of violacein for non-tumor
cells occurs in the range of 5–10 μM [4, 5, 19], while the
Fig. 3 Status of the antioxidant apparatus after violacein treatment. a SOD activity in CHO-K1, MRC-5 and HeLa cells exposed to 0.75–6 μM violacein for
24 h. SOD activity was expressed as U/mL/mg protein. Standard controls using SOD yielded 15.4 U/mL/mg protein of enzymatic activity. b Catalase activity
in CHO-K1, MRC-5 and HeLa cells exposed to 0.75–6 μM violacein for 24 h. Catalase activity was expressed as nmol/min/mg protein. Standard controls
using CAT yielded 12.3 nmol/min/mg protein of enzymatic activity. c Alterations in the GSH levels of CHO-K1, MRC-5 and HeLa cells exposed to 0.75–6 μM
violacein for 24 h. The results are presented as the means ± SD of three experiments run in triplicate (*p< 0.05 treated vs. control). C denotes control
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1–5 μM [5, 16, 20], findings that are in agreement with
the data obtained in our work. Concerning tumor cells,
the most promising results were obtained with the cell
lines MOLT-4 (leukemia), NCI-H460 (lung cancer) and
KM12 (colon cancer), in which very low violacein con-
centrations (0.03–0.06 μM) showed cytotoxicity [4].
Moreover, in melanoma 92.1andOCM-1 cells, the cyto-
toxicity was exhibited in the range of 1.69–3.69 μM [20].
In our work, violacein cytotoxicity was highest at 6 μM.
Indeed, variations in violacein cytotoxicity are observed
depending on the cell type, indicating the occurrence of
violacein cell-type-specific mechanisms [5, 16].
Previously, the cytotoxicity induced by violacein was
attributed to ROS generation [5, 16], despite its antioxi-
dant activity observed in vitro [15]. Here, we analyzed
the induction of antioxidant enzymes and occurrence of
oxidative stress biomarkers in cells treated with violacein
to identify the association between oxidative stress and
cell death. We observed that certain concentrations of
violacein induced SOD activity in CHO-K1 and MRC-5
cells, but a dose-dependent response was not obtained.
Concerning catalase activity, significant differences werenot observed. Interestingly, catalase activity was reduced
in MRC-5 cells after the treatment with 1.5 μM viola-
cein, but the cause of this inhibition is unclear. Despite
the relationship between SOD and catalase activities
[21], the non-concomitant increase in the activity of
these enzymes has been demonstrated [22], as observed
in our work.
According to Bromberg et al. [5], treatment with viola-
cein (2–5 μM) led to the reduction of GSH levels in
EAT cells. Similarly, in our work, a significant decrease
in GSH levels was observed in HeLa cells treated with
specific concentrations of violacein. However, the GSH
depletion in HeLa cells may be caused by mechanisms
other than an excessive level of ROS. In fact, we ob-
served the induction of SOD and occurrence of oxidative
stress biomarkers for certain concentrations of violacein
(Figs. 3 and 4). However, these data do not support the
role of ROS in the cell death observed after treatment
because dose-dependent responses were not observed.
Interestingly, the increase of membrane potential was
detected even at the lowest violacein concentration
tested, suggesting that violacein toxicity is associated with
mitochondria damage. Comparing these results with the
Fig. 4 Analysis of biomarkers of oxidative stress after treatments with violacein. a Protein carbonylation in CHO-K1, MRC-5 and HeLa cells exposed
to 0.75–6 μM violacein for 24 h. b Lipid hydroperoxide (LPO) levels (μM) in CHO-K1, MRC-5 and HeLa cells exposed to 0.75–6 μM violacein 24 h.
c 8-iso PGF2a levels (pg/mL) in CHO-K1, MRC-5 and HeLa cells exposed to 0.75–6 μM violacein for 24 h. d 8-oxoG quantification in CHO-K1, MRC-5 and
HeLa cells exposed to 0.75–6 μM violacein for 24 h. The results are expressed as the means ± SD of three experiments run in triplicate (*p < 0.05 treated
vs. control). C denotes control
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cytotoxicity and the increase of mitochondrial membrane
potential might be indicative that cytotoxicity caused by
violacein occurs through the mitochondrial pathway.
However, the differences observed in cell viability and theFig. 5 Effects of violacein on the mitochondrial membrane potential of
CHO-K1, MRC-5 and HeLa cells. Cells were stained with Rhodamine 123
and analyzed by flow cytometry in the FL-1 (FITC) channel. The results
are expressed as the means ± SD of three experiments run in triplicate
(*p < 0.05 treated vs. control). C denotes controlproportions of cells in apoptosis and/or necrosis (Fig. 2)
suggest the occurrence of cell-type-specific mechanisms.
Previous study [23] carried out with 2,237 fibrosarcoma
cells treated for 48 h with PVP, a violacein-like pigment
from the Antarctic Janthinobacterium sp bacteria, showed
that the treatment induced the disruption of the mito-
chondrial membrane potential and occurrence of apop-
tosis via the mitochondrial pathway. Furthermore, another
cell death mechanism has been suggested by Queiroz et
al. [6], showing the effect of violacein on TF1 leukemia
cells by the induction of cellular suicide, by a mechanism
involving the endoplasmic reticulum, Golgi linearization
and ‘horseshoe-shaped’ nuclei. Melo et al. demonstrated
that the treatment of HL60 cells with violacein induced
cytotoxic effects and cell differentiation, which may be
related to alterations in phospholipid asymmetry and
changes in mitochondrial polarization [24]. In addition, the
violacein-dependent association of TRAF2 with the TNF
receptor was observed by co-immunoprecipitation assays,
suggesting that apoptosis of HL60 cells mediated by viola-
cein occurs by specific activation of TNF receptor 1 [25].
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pate in the induction of cell death and has been suggested
to be central to the apoptotic pathway [26]. Indeed, early
hyperpolarization of mitochondrial membrane has been
reported as an event that occurs in several cell death path-
ways [27–29]. Collectively, the results suggest that viola-
cein induces cell death of both MRC-5 and HeLa cells
through the hyperpolarization of the mitochondrial mem-
brane potential, acting through a mitochondrial pathway.
By contrast, in CHO-K1 cells, the cytotoxic effects of vio-
lacein may be related to other mechanisms specific for this
cell line.
Conclusion
In conclusion, although violacein induced SOD activity and
increased certain oxidative stress biomarkers, oxidative
stress does not seem to be the major cause of cell death ob-
served after the treatment because dose-dependent re-
sponses were not observed. Interestingly, in MRC-5 and
HeLa cells, the hyperpolarization of the mitochondrial
membrane potential may be related to cell death triggered
by violacein. Due to the pharmacological potential of viola-
cein, a better understanding of the cell death mechanisms






one) [9, 10, 30] was kindly provided by Dr. Regina
Vasconcellos Antonio (BQM-UFSC, Brazil). Violacein was
dissolved in DMSO (dimethyl sulfoxide; Merck, Germany)
and added to the cultured medium to a final DMSO con-
centration of less than 0.1 % (vol/vol). The violacein was
stored at 4 °C, protected from light and diluted in fresh
cell culture medium prior to use.
Cytotoxicity assays
To evaluate the cytotoxic effects of violacein, MRC-5
(human fetal lung fibroblast), CHO-K1 (Chinese ham-
ster ovary) and HeLa (human cervical adenocarcinoma)
cells were cultured in flasks containing DMEM medium
(Gibco, USA) supplemented with 10 % fetal bovine
serum (FBS) and antibiotics (100 U/mL of penicillin and
100 μg/mL of streptomycin) (Gibco) in a CO2 incubator at
37 °C. For the cytotoxicity assays, cells were seeded (3 × 105
cells mL−1/well) in 6-well plates for 24 h and exposed to
0.75–6 μM violacein for 24 and 48 h. Next, the cell mono-
layers were washed three times with cold PBS, pH 7.4, har-
vested using a 1× trypsin-EDTA solution (Gibco) and
resuspended in fresh DMEM medium. Cell viability
was measured using the Trypan blue dye exclusion
method [31].To evaluate the occurrence of cell death by apoptosis
or necrosis, the cells were treated as described above.
After the treatments, cells were briefly washed in cold
PBS, pH 7.4, and collected by trypsinization. The cell
pellets were resuspended in a binding buffer (1 × 106/mL
cell density) and stained with 5 μL of Annexin V-FITC
and 5 μL of propidium iodide (PI), as indicated in the
FITC Annexin V Apoptosis Detection Kit I (Catalog
No.556547; BD PharmingenTM, USA). The cells were in-
cubated in the dark at room temperature for 15 min and
analyzed on a FACSCANTO II flow cytometry system
(BD Biosciences, USA). For each sample, 30,000 events
were collected, and the analysis was performed using
Flowjo 7.6.4 software (Treestar Ashland, USA).
SOD and Catalase activities
Violacein-exposed cells were washed twice by resuspen-
sion in cold PBS, pH 7.4, and the cell pellets were soni-
cated in a cold buffer (20 mM HEPES buffer (Amresco,
USA), pH 7.2, containing 1 mM EGTA (ethylene glycol
tetraacetic acid; Sigma-Aldrich, USA), 210 mM mannitol
and 70 mM sucrose) using the Ultrasonic processor
(Sonic vibraCellTM, Canada). SOD activity was evaluated
as indicated in the Superoxide Dismutase Assay Kit
(Catalog No.706002; Cayman Chemical Company, USA).
For catalase activity measurements, cells were treated,
washed twice in PBS, pH 7.4, sonicated in a cold buffer
(50 mM potassium phosphate, pH 7.0, containing 1 mM
EDTA) and tested for enzymatic activity as indicated in
the Catalase Assay Kit (Catalog No.707002; Cayman
Chemical Company). Protein quantification was deter-
mined by the Bradford assay [32].
GSH levels
To determine whether violacein can reduce cellular GSH
levels, cells were washed twice in cold PBS, pH 7.4, and the
cell pellets were homogenized in a cold buffer (50 mM
MES, pH 7.0, containing 1 mM EDTA). The supernatant
was stored on ice and deproteinized using metaphosphoric
acid and triethanolamine at 0.1 g/mL and 4 M, respectively.
Deproteinized samples were used to assay total GSH (both
oxidized and reduced forms) as indicated in the Glutathi-
one Assay Kit (Catalog No. 703002, Cayman Chemical
Company). The normalization was based the protein con-
tent of samples as determined by the Bradford assay [32].
Membrane lipid peroxidation assays: Lipid hydroperoxides
(LPOs) and 8-Isoprostanes (8-iso PGF2a)
After incubation with violacein, cells were washed twice
by resuspension in cold PBS, pH 7.4, and the cell pel-
lets were sonicated in HPLC-grade water. The LPOs
and (8-iso PGF2a) were extracted and quantified as indi-
cated in the Lipid Hydroperoxide Assay Kit (Catalog No.
705003; Cayman Chemical Company) and 8-Isoprostane
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Protein carbonyls
Total protein was extracted as described in [33] with mod-
ifications. Cells were centrifuged, collected in cold PBS
and incubated in lysis buffer (50mMTris-HCl, 150 mM
NaCl, 0.1 % SDS, HPLC-ultrapure grade water, protease
inhibitors (1:100) (Merck) and 25 U DNase benzonase
(Merck) for 20 min at 4 °C. After lysis, the supernatants
containing total protein extracts were recovered and the
proteins quantified by the Bradford method [32]. After
that, protein carbonyls were quantified as proposed by
Hawkins et al. [34].
Detection of 8-oxoguanine
Initially, cells at 105 cells mL−1/well density were seeded
in 96-well plates for 24 h and treated with violacein.
Next, cells were fixed in methanol at −20 °C (Labsynth)
for 20 min, washed in cold PBS and permeabilized with
PBS containing 0.1 % Triton X-100 (USB corporation).
Nonspecific ligation events were blocked by incubating
cells in PBS containing 10 % FBS for 1 h. Finally, the
cells were incubated in the dark at 37 °C in PBS contain-
ing FITC-avidin (Sigma-Aldrich) (1:200 dilution) for 1 h.
After four washes in PBS containing 10 % FBS, fluores-
cence was detected at 485 nm excitation and 535 emis-
sion (GloMax®-Multi Detection System; Promega, USA).
Mitochondrial dysfunction evaluation
Changes in the mitochondrial transmembrane potential
were assayed through the incorporation of Rhodamine
123 (Rh123) (Sigma-Aldrich), a mitochondrial-specific
cationic fluorescent dye. After treatments, cells were re-
suspended at 1 × 105/mL in cold PBS and permeabilized
with methanol at −20 °C (Labsynth) and incubated with
10 μg/mL of Rh123 (Sigma-Aldrich) for 30 min at 37 °C
in the dark. For fluorescence-activated cell sorter (FACS)
analysis, 30,000 events for each sample were acquired in
the FACSCANTO II system (BD Biosciences), at wave-
lengths of 488 nm for excitation and 525 nm for emission
as proposed by Li et al. [35]. The analysis was performed
using Flowjo 7.6.4 software (Treestar Ashland, USA).
Statistical analysis
Values are presented as the means ± standard deviation
(SD) of three independent experiments, and statistical
significance was set as a p value less than 0.05. Signifi-
cance was determined by analysis of variance followed
by the Dunnett’s or Bonferroni post-hoc test (GraphPad
Prism 5.0 program).
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